# OnCo record rtog-0415 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/rtog-0415/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "rtog-0415", "NCT00331773" ;
  schema:name "RTOG 0415"@en ;
  schema:alternateName "RTOG 0415"@en, "NRG Oncology RTOG 0415"@en ;
  schema:description "Showed that men with low-risk prostate cancer can have five and a half weeks of radiotherapy instead of eight without losing control of the cancer, at the price of slightly more bowel and bladder trouble later."@en ;
  schema:url <https://onco.cc/trials/rtog-0415/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00331773>, <https://doi.org/10.1200/JCO.2016.67.0448> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/> ;
  onco:technologies <https://onco.cc/technologies/hypofractionated-radiotherapy/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:companies <https://onco.cc/companies/nrg-oncology/> ;
  onco:terms <https://onco.cc/terms/hypofractionation/>, <https://onco.cc/terms/curative-intent/>, <https://onco.cc/terms/psa/> ;
  onco:trials <https://onco.cc/trials/chhip/>, <https://onco.cc/trials/profit-trial/>, <https://onco.cc/trials/hypo-rt-pc/>, <https://onco.cc/trials/pace-b/> .